DSIP (Delta Sleep-Inducing Peptide): Structure and Research Background

Key Takeaways

Understanding Delta Sleep-Inducing Peptide (DSIP)

The chemical structure of DSIP, classified as a nonapeptide, plays a crucial role in its stability and functionality within the body.

What is DSIP?

Delta Sleep-Inducing Peptide (DSIP) is composed of a specific sequence of amino acids: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE). This unique sequence allows DSIP to be highly resistant to degradation, making it stable at room temperature and capable of crossing the blood-brain barrier. These properties are essential for its interaction with various physiological processes within the brain and other organs.

Wholesale Peptide offers high-quality DSIP for research purposes, ensuring that researchers have access to this promising peptide for their studies.

Sources and synthesis

DSIP is a naturally occurring substance found in various parts of the body, including the brain, heart, kidneys, and liver. Interestingly, DSIP has a similar presence in nearly every organ system as melatonin, indicating its widespread influence on physiological processes, including the action of an unknown hypothalamic hormone.

Researchers at Loti Labs continue to explore the synthesis and functions of DSIP, contributing to our understanding of this intriguing peptide.

Mechanisms of Action

Interaction with neurotransmitters

Potential Research Applications

Wholesale Peptide supports these research efforts by providing high-quality DSIP for scientific investigations.

By influencing brain health and neuroinflammation processes, DSIP may play a significant role in protecting the central nervous system from damage.

Current Research and Studies

While the findings from animal studies are promising, a clinical pilot study on human sleep subjects has been limited and inconclusive.

Animal studies

These findings suggest that DSIP may play a significant role in developing novel therapies for neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

Wholesale Peptide provides high-quality DSIP for these important scientific investigations.

Human plasma DSIP decreases

Summary

Wholesale Peptide is committed to supporting these research efforts by providing high-quality DSIP for laboratory studies. The future of DSIP research holds exciting possibilities, and we look forward to uncovering more about this fascinating peptide.

Frequently Asked Questions

What is Delta Sleep-Inducing Peptide (DSIP)?

What are the potential research applications of DSIP?

How does DSIP interact with neurotransmitters?

This interaction underscores its role in the regulation of physiological responses.

What current research exists on DSIP?

How is DSIP peptide administered?

Is DSIP FDA approved?

No. DSIP is not FDA-approved for any therapeutic indication and is classified strictly as an investigational research compound. It carries no approved clinical application as of 2026.

References

1. Schoenenberger GA, Monnier M. Proc Natl Acad Sci USA. 1977;74(3):1282-6.
2. Kastin AJ, Banks WA. Peptides. 1986;7(6):1165-87.
3. Friedman TC, Garcia-Borreguero D, Hardwick D, et al. J Clin Endocrinol Metab. 1994;78(5):1085-9.
4. Schneider-Helmert D, Schoenenberger GA. Neuropsychobiology. 1983;9(4):197-206.
5. Graf MV, Kastin AJ, Fischman AJ. DSIP occurs in free form in mammalian plasma, human CSF and urine. Pharmacol Biochem Behav. 1984;21(5):761-6.
6. Banks WA, Kastin AJ, Selznick JK. Modulation of immunoactive levels of DSIP and blood-brain permeability by lighting and diurnal rhythm. J Neurosci Res. 1985;14(3):347-55.
7. Monti JM, Debellis J, Alterwain P, Pellejero T, Monti D. Int J Clin Pharmacol Res. 1987;7(2):105-10.
8. Susic V. Physiol Behav. 1987;40(5):569-72.
9. Shandra AA, Godlevskii LS, Brusentsov AI, et al. Neurosci Behav Physiol. 1998;28(5):443-6.
10. Lindstrom LH, Ekman R, Walleus H, Widerlov E. Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(1-2):83-90.